Chemical Works of Gedeon Richter Plc GDR RegS
No trades
No trades
3.6 USD
658.91 M USD
2.63 B USD
Company info
Sector
Industry
CEO
Gábor Orbán
Website
Headquarters
Budapest
Founded
1901
IPO date
Nov 9, 1994
ISIN
US3684672054
CUSIP
368467205
FIGI
BBG000GGZ2S3
Identifiers
ISIN US3684672054
Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. The firm focuses on central nervous system, women's healthcare, cardiovascular, and OTC products. It operates through the following segments: Neuropsychiatry (CNS), General Medicines (GM), Women’s Healthcare (WHC), Biotechnology (BIO), and Pharma Other. The CNS segment focuses on building a pipeline of small molecule drug candidates mainly in the field of neuropsychiatry. The GM segment includes a traditional and generic portfolio in various therapeutic areas in the Central and Eastern European regions. The WHC segment provides pharmaceutical products for European women. The BIO segment is involved in its biotechnology platform to develop and manufacture biosimilar drugs for global markets. The Pharma Other segment relates to the remaining wholesale and retail business of the Group and all other activities. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateJun 4, 2031
Coupon1.75% (Fixed)
See all CHWGR bonds